Who owns ZHENGYE BIOTECHNOLOGY HLDG L?
- Ticker: ZYBT
- CUSIP Number: g989ms101
Tip: Access positions for across all investors
Analyze quarterly positions in Zhengye Biotechnology Hldg L with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Zhengye Biotechnology Hldg L stock
Who bought or sold ZHENGYE BIOTECHNOLOGY HLDG L this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Invesco | 37k | $96k | -1% | Sep 2025 |
|
| XTX Topco | 35k | $91k | 100% | Sep 2025 |
|
| Geode Capital Management | 29k | $76k | 0% | Sep 2025 |
|
| Winton Capital | 22k | $57k | 100% | Sep 2025 |
|
| Millennium Management | 15k | $38k | 100% | Sep 2025 |
|
| Citadel Advisors | 12k | $31k | 100% | Sep 2025 |
|
| Tower Research Capital | 4.5k | $12k | 34% | Sep 2025 |
|
| UBS Group | 4.3k | $11k | -97% | Sep 2025 |
|
| Morgan Stanley | 2.4k | $15k | 100% | Jun 2025 |
|
| Caitong International Asset Management | 1.00 | $3.000000 | 100% | Sep 2025 |
|
Who sold out of Zhengye Biotechnology Hldg L?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Jane Street | Jun 2025 | 194k | $1.2M |
| Bnp Paribas Arbitrage, Snc | Jun 2025 | 262.00 | $1.6k |
| Royal Bank of Canada | Jun 2025 | 34.00 | $0 |